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Polymorphisms of Jak3 contribute to diminished promoter activity 
and increased risk of lung cancer in Korea populations
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In process lung SNP(single nucleotide polymorphism) targeting stud-
ies, we knew that JAK-STAT signaling pathway is responsible for 
several apoptotic and cell cycle regulatory proteins. The family of Jak 
kinases is composed from at least four non-receptor kinases(Tyk2, 
Jak1, Jak2, Jak3). In generally, Jak3 is related lymphoid development, 
immune function and innate genetic disease. But, Jak3 is not well 
deﬁned SNP studies of promoter region in lung cancer.
Therefore, we investigated whether SNPs of Jak3 promoter are 
associated with Korean lung cancer patients. We analyzed 5 SNP 
points(-1514, -866, -672, 64 and 227) of Jak3 promoter by using the 
genomic DNA from 320 Korea lung cancer patients and 268 healthy 
controls. Genotyping was performed by the SNP-IT, SNapShot assay 
and Restriction Fragment Length Polymorphism (RFLP). The allele 
frequencies of each SNP between lung cancer patients and controls 
were estimated by the chi-square tests and odds rations (OR) with 95% 
conﬁdence interval (95% CI). We explored the association between 
SNP points and histopathological factors of the lung cancer patients. 
Also, using these 5 SNPs, linkage disequilibrium and haplotype pat-
terns were examined. 
To these 5 SNP points, -672 point was associated with lung cancer 
risks. In case of -672 SNP point, subgroup analysis of clinicopathologic 
parameters in cancer group showed signiﬁcant differences in male, 
non-smoker and non-drinker. In vitro assay, transfection of A549, 
H1666, Calu1 and H1299 NSCLC cell lines with luciferase reporter 
constructs containing 769 bp of the -672 point(-672 G/A) showed dif-
ference luciferase activity expression patterns.
In conclusion, we conﬁrmed a relation between the Jak3 gene poly-
morphisms and signiﬁcant increased risk in certain subgroup of lung 
cancer patients. SNPs of Korean lung cancer patient in Jak3 promoter 
are related to clinicopathologic parameters in male, non-smoker and 
non-drinker.
In this study, we investigated to single nucleotide polymorphisms 
(SNPs) in the JAK3 and the relationships between the SNPs and the 
risk of lung cancer occurrence in Korean lung cancer patients compared 
to normal controls. This is the ﬁrst study to provide evidence for an as-
sociation of JAK3 gene polymorphisms with lung cancer risk.
This study was supported by a Grant of the Korea Health 21 R&D proj-
ect, the Ministry of Health & Welfare, Republic of Korea (A010250)
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The molecular mechanism of Nm23-H1 gene transfection on 
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metastatic large cell lung cancer cell line L9981
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Background: Our previous studies have proved that nm23-H1 gene 
was a tumor metastatic suppressive gene, tumor metastasis phenotype 
of human lung cancer could be reversed by transfection of nm23-H1 
cDNA, but the molecular mechanism of nm23-H1 for inhibiting tumor 
invasion and metastasis is unclear. The aim of this study is to explore the 
molecular mechanism of nm23-H1 reversing the invasion and metastasis 
phenotype in human high-metastatic large cell lung cancer line L9981. 
Methods: The cell growth and the invasive ability were detected in 
L9981 (the primary lung cancer cell line), L9981-pLXSN (the lung 
cancer cell line transfected with vector) and L9981-nm23-H1 (the lung 
cancer cell line transfected with nm23-H1) by MTT assay and modiﬁed 
Boyden chamber, respectively. The mRNA and protein expression of β-
Ccatenin, E-Cadherin, CD44S, CD44V6, MMP-2, TIMP-1, VEGF were 
detected in the same three lung cancer cell lines by RT-PCR and Western 
blot. The change of gene expression and signal transduction were deter-
mined before and after transfection of nm23-H1 gene by microassay. 
Results: Cell proliferation, clone formation and invasive ability in the 
L9981-nm23-H1 lung cancer cell line transfected with nm23-H1 gene 
were signiﬁcantly lower than those in L9981 and L9981-pLXSN lung 
cancer cell lines(P<0.001).No Signiﬁcant difference of cell prolifera-
tion, clone formation and invasive ability was observed between in 
L9981 and L9981- pLXSN lung cancer cell line(P<0.05). The mRNA 
and protein expression of β-Ccatenin, E-Cadherin, TIMP-1 were sig-
niﬁcantly up-regulated in L9981- nm23-H1 lung cancer cell line trans-
fected with nm23-H1 cDNA than those in L9981 and L9981-pLXSN 
lung cancer cell lines (P<0.001), but no signiﬁcant difference of mRNA 
and protein expression of β-Catenin, E-Cadherin and TIMP-1 existed 
between L9981 and L9981-pLXSN lung cancer cell line(P<0.05). The 
mRNA and protein expression of MMP-2, CD446V and VEGF were 
signiﬁcantly down-regulated in the L9981-nm23-H1 lung cancer cell 
line than those in L9981 and L9981-pLXSN lung cancer cell lines 
(P<0.001), but no signiﬁcant difference of mRNA and protein expres-
sion of MMP-2, CD446V and VEGF existed between L9981 and 
L9981-pLXSN lung cancer cell line(P>0.05). 24 gene related to metas-
tasis were upregulated and 34 gene related to metastasis were down-
regulated after transfection of nm23-H1 gene. 36 genes related to signal 
pathway were up-regulated and 29 genes related to signal pathway 
were down-regulated after transfection of nm23-H1 gene. 
Conclusions: (1) nm23-H1 might be a key regulatory gene of metastsis 
related genes and it may play an important role in the Lung Cancer 
Metastatic Suppressive Cascde. (2) nm23-H1 gene can reverse the 
invasive and metastasis phenotype of human high-metastatic large cell 
pulmonary carcinoma cell line L9981 through regulation of the expres-
sion of metastatic genes and signal transduction pathway.
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Double mutant P96S/S120G of Nm23-H1 abrogates its NDPK 
activity and motility-suppressive ability*
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Background: The Nm23-H1 gene is a metastasis suppressor gene. 
However, its biochemical mechanism of suppressing the met static 
potential of cancer cells is still unknown. The previous hypothesis that 
a histidine protein kinase activity may contributes to the motility-sup-
pressive effect of Nm23-H1 could not explain why the H118F mutant, 
a kinase-deﬁcient mutant, still had motility-suppressive ability. 
Methods: We conducted a study on the double mutant P96S/S120G 
of Nm223-H1 and succeeded in introducing the RP-HPLC method in 
NDPK assay. 
Results: The results showed that double mutant P96S/S120G, when 
expressed in the bacteria, was completely aggregated in inclusion 
bodies; prompted that the deﬁciency of motility-suppressive fuction of 
S120G, P96S, and P96S/S120G mutants was due to their altered struc-
ture, which might deprive Nm23-H1 of most activities including kinase 
activity or interactions with other proteins.
Conculsions: Double mutant P96S/S120G of Nm23-H1 abrogates its 
NDPK activity and motility-suppressive ability in the human high-
metastatic large cell lung cancer cell line L9981.
*This work was partly supported by the grants from the Key Proj-
ect of National Natural Science Foundation of China (to Qinghua 
Zhou)(No. 30430300), National Natural Science Foundation of China 
(to Qinghua Zhou) (No. 30070333), and the Research Found for the 
Doctoral Program of Higher Education of China (to Qinghua Zhou) 
(No. 20040610060) .
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Novel mechanism of collagen-tumor cell interaction by integrin 
alpha-11 expression by cancer associated fibroblasts in non-small 
cell lung cancer cells
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Background: The integrin α11 subunit is commonly overexpressed 
in non-small cell lung carcinoma (NSCLC). α11β1 integrin is a one of 
the four receptors for interstitial collagen. Immunoﬂuorescence study 
localized the protein mainly to the tumor stroma. α11 is also commonly 
overexpressed in cancer-associated ﬁbroblasts. We hypothesized that 
stromal expression of α11 may play important role in regulating the 
tumor formation of NSCLC cells. 
Methods: SV40 immortalized mouse embryonic ﬁbroblasts established 
from the wild type (WT) and α11 deﬁcient (KO) mice were tested for 
their tumorigenicity in immune deﬁcient mice when co-implanted with 
the A549 human lung adenocarcinoma cells. Fibroblasts and A549 
alone served as controls. Total cellular RNA was isolated from tumors 
formed and proﬁled using the Affymetrix U133A microarray, and 
differentially expressed genes were identiﬁed. Stable gene expression 
downregulation was accomplished by retroviral mediated transduction 
of short hairpin (sh) RNA. 
Results: A549 co-implanted with the ﬁbroblasts showed markedly 
increased tumor growth rate as compared with all control cell lines 
alone, which formed only small tumors. Importantly, the growth was 
signiﬁcantly greater for A549+WT compared to A549+KO tumors. The 
reduced tumorigenicity was also rescued by re-expression of human 
α11 in KO ﬁbroblasts. The tumor-promoting effect of ﬁbroblast α11 
was reproduced in 2 other NSCLC cell lines: NCI-H460 and -H520. 
Gene expression proﬁling indicated that IGF2 mRNA expression level 
was tightly regulated by alpha-11 in the ﬁbroblasts, and A549+KO tu-
mors expressed >200-fold lower IGF2 compared to A549+WT tumors. 
The shRNA downregulation of IGF2 in WT (WTsh-IGF2) ﬁbroblasts 
resulted in decreased growth rate of A549+WTsh-IGF2 compared to 
A549+WT tumors. In the orthotopic NCI-H460 human lung cancer 
model, host stromal α11 expression was signiﬁcantly higher in meta-
static compared to the primary tumors. 
Conclusion: Integrin α11 expressed on tumor stromal ﬁbroblasts 
provide a novel and alternate mechanism for collagen to modulate the 
growth of NSCLC cells, and IGF2 is one of the mediators for such 
activity. 
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Reverse transcriptase polymerase chain reaction assay designed 
for the detection of LUNX-mRNA to compare the micrometastasis 
during chemotherapy in patients with non-small cell lung cancer
Huang, Yisheng; Wu, Yilong; Huang, Yujuan; Yang, Jinji; 
Liao, Riqiang 
Guangdong Provincial People’s Hospital, Guangzhou, China
Objective: To compare the micrometastasis during chemotherapy in 
patients with non-small cell lung cancer. 
Material and Methods: To detect the expression of the lung tissue 
speciﬁc gene named LUNX with reverse transcriptase chain reaction 
method (RT-PCR) in peripheral blood of patients with non-small cell 
lung cancer (NSCLC), the micrometastasis of non-small cell lung 
cancer was diagnosed. 
Result: Total 20 patients was involved in the study, the peripheral 
blood was sampled before and after two cycles chemotherapy. There 
were 7 patients with NSCLC showed LUNX gene expression in blood 
before chemotherapy by RT-PCR.After two cycles of chemotherapy, 
there were 2 patients who was positive in blood detection. The positive 
detection rate of in peripheral blood in the group of before chemother-
